Hematology Activities
Novel Immunotherapy Options for the Long-term Care of Patients with Chronic Lymphocytic Leukemia (CLL): The Role of Clinical and Specialty Pharmacists
0290-0000-18-140-L01-P
Pharmacists must focus on managing and counseling patients with CLL and healthcare professionals about adverse events and available novel immunotherapeutic options.
9-18-2018
1.50
An American Journal of Managed Care Symposium:
Examining the Impact of Extended Half-Life Clotting Factors on the Managed Care Setting - Featuring a Patient Perspective
0290-0000-18-137-H01-P
This activity will feature an interactive discussion on the role of extended half-life products in hemophilia treatment as it relates to managed care.
1.50
Clinical Utility of Pharmacokinetic Analysis in The Treatment of Hemophilia A: Assessing PK Parameters Beyond Half-Life
0290-0000-18-138-L01-P
This activity from PTCE will focus on examining new extended half-life therapies for hemophilia A, an analysis of pharmacokinetics, and more.
8-20-2018
1.00
A Review of Recent and Emerging Therapies for the Care of Relapsed and Refractory B-Cell Acute Lymphocytic Leukemia (R/R ALL)
0290-0000-18-125-L01-P
This webinar from PTCE will provide the knowledge and necessary tools to apply their skills and training to give optimal care to patients with ALL.
9-25-2018
1.00